In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist experienced improvements in their quality of life.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/biologic-plus-glp-1-agonist-improves-quality-life-psoriatic-2026a10002s0?src=rss
Author :
Publish date : 2026-01-28 21:28:00
Copyright for syndicated content belongs to the linked Source.